Genotype-Phenotype Relationship among 785 Unrelated White Women with Inherited Congenital Factor VII Deficiency: A Three-Center Database Study
- PMID: 38202056
- PMCID: PMC10779797
- DOI: 10.3390/jcm13010049
Genotype-Phenotype Relationship among 785 Unrelated White Women with Inherited Congenital Factor VII Deficiency: A Three-Center Database Study
Abstract
Background: Congenital factor VII (FVII) deficiency, a rare bleeding disorder resulting from mutations in the F7 gene with autosomal recessive inheritance, exhibits clinical heterogeneity that lacks a strong correlation with FVII:C levels. The objective of this study was to discern genetic defects and assess their associations with the clinical phenotype in a substantial cohort comprising 785 white women exhibiting FVII:C levels below the age-dependent cut-off percentage.
Patients and methods: Individuals with verified inherited factor VII deficiency underwent i) genotyping using the Sanger method and multiplex ligation-dependent probe amplification (MLPA) to identify F7 mutations, including common polymorphic variants. Additionally, they were ii) categorized based on clinical bleeding scores (BS). Thrombophilic variants and blood groups were also determined in the study participants.
Results: The probands in this study encompassed both asymptomatic individuals (referred for a laboratory investigation due to recurrent prolonged prothrombin time; n = 221) and patients who manifested mild, moderate, or severe bleeding episodes (n = 564). The spectrum of bleeding symptoms included epistaxis, gum bleeding, gastrointestinal bleeding, hematuria, postoperative bleeding, and gynecologic hemorrhage. The median ISTH bleeding score (BS) recorded within a two-year period prior to the work-up was 2 (0-17). Notably, this score was significantly higher in symptomatic women compared to their asymptomatic counterparts (3 versus 0; p < 0.001). The corresponding PBAC score before hormonal treatment stood at 225 (5-1200), exhibiting a positive correlation with the ISTH BS (rho = 0.38; p = 0.001). Blood group O was more prevalent in symptomatic women compared to asymptomatic individuals (58 versus 42%; p = 0.01). Among the 329 women (42%), known and novel mutations in the F7 gene, encompassing coding regions, exon/intron boundaries, and the promoter region, were identified, while common polymorphisms were detected in 647 subjects (95%). Logistic regression analysis, adjusted for clinical and laboratory data (including blood group, FVII activity, the presence of F7 gene mutations and/or polymorphisms, thrombophilia status, and additional factor deficiencies) revealed that older age at referral (increase per year) (odds/95% CI: 1.02/1.007-1.03), the presence of blood group O (odds/95% CI: 1.9/1.2-3.3), and the coexistence of further bleeding defects (odds/95% CI: 1.8/1.03-3.1) partially account for the differences in the clinical bleeding phenotype associated with FVII deficiency.
Conclusion: The clinical phenotype in individuals with FVII deficiency is impacted by factors such as age, blood group, and the concurrent presence of other bleeding defects.
Keywords: factor VII deficiency; genotype–phenotype relationship; rare coagulation disorders.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency. Results from a genotype-phenotype study.Thromb Haemost. 2017 Aug 1;117(8):1455-1464. doi: 10.1160/TH17-02-0085. Epub 2017 Apr 27. Thromb Haemost. 2017. PMID: 28447100
-
Genotype and phenotype relationships in 10 Pakistani unrelated patients with inherited factor VII deficiency.Haemophilia. 2013 Nov;19(6):893-7. doi: 10.1111/hae.12186. Epub 2013 Jun 4. Haemophilia. 2013. PMID: 23731332
-
Clinical phenotype and F7 gene genotype in 40 Tunisian patients with congenital factor VII deficiency.Blood Coagul Fibrinolysis. 2022 Jul 1;33(5):280-284. doi: 10.1097/MBC.0000000000001139. Epub 2022 Jun 27. Blood Coagul Fibrinolysis. 2022. PMID: 35802509
-
Factor VII deficiency: defining the clinical picture and optimizing therapeutic options.Haemophilia. 2008 Nov;14(6):1170-5. doi: 10.1111/j.1365-2516.2008.01844.x. Haemophilia. 2008. PMID: 19141157 Review.
-
Factor VII Deficiency.Semin Thromb Hemost. 2009 Jun;35(4):400-6. doi: 10.1055/s-0029-1225762. Epub 2009 Jul 13. Semin Thromb Hemost. 2009. PMID: 19598068 Review.
Cited by
-
Bleeding Symptoms in Pediatric Patients with Congenital FVII Deficiency and Correlation to Thrombin Generation Assay Parameters: A Single-Center Retrospective Analysis.Life (Basel). 2024 Nov 27;14(12):1559. doi: 10.3390/life14121559. Life (Basel). 2024. PMID: 39768267 Free PMC article.
-
Genetic Landscape of Factor VII Deficiency: Insights from a Comprehensive Analysis of Pathogenic Variants and Their Impact on Coagulation Activity.Int J Mol Sci. 2024 Feb 17;25(4):2384. doi: 10.3390/ijms25042384. Int J Mol Sci. 2024. PMID: 38397060 Free PMC article.
-
Compound heterozygous mutations (p.L68R∗37 and p.T241N) lead to abnormal protein levels and structures in hereditary FVII deficiency.Blood Coagul Fibrinolysis. 2025 Mar 1;36(2):44-50. doi: 10.1097/MBC.0000000000001340. Epub 2025 Jan 6. Blood Coagul Fibrinolysis. 2025. PMID: 39817833 Free PMC article.
References
-
- Mariani G., Herrmann F.H., Bernardi F., Schved J.F., Auerswald G., Ingerslev J. Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: The International Registry on Congenital Factor VII Deficiency (IRF7) Blood. 2000;96:374. doi: 10.1182/blood.V96.1.374. - DOI - PubMed
-
- Di Minno M.N.D., Dolce A., Mariani G., STER Study Group Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency. Thromb. Haemost. 2013;109:1051–1059. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous